ARTICLE | Company News
Epizyme, GlaxoSmithKline deal
March 10, 2014 7:00 AM UTC
Epizyme will receive a $2 million milestone payment from GlaxoSmithKline under a January 2011 deal in which the companies partnered to discover, develop and commercialize small molecule therapeutics t...